Thromboangiitis Obliterans (Buerger’s Disease)
Journal: International Research Journal of Pharmacy and Medical Sciences (IRJPMS) (Vol.2, No. 5)Publication Date: 2019-09-10
Authors : Ketan Vagholkar; Shantanu Chandrashekhar; Dhairya Chitalia; Anmol Sahoo; Suvarna Vagholkar;
Page : 50-52
Keywords : ;
Abstract
Thromboangiitis Obliterans (TAO) is a non-atherosclerotic segmental inflammatory disease predominantly affecting the medium to small sized arteries and veins of both lower and upper extremities. Cigarette smoking is the most important contributing factor in the development of the disease. The disease is assuming alarming proportions on the Indian subcontinent. Clinical features and investigations constitute the basis of an early diagnosis of thromboangiitis obliterans. Abstinence from smoking is the mainstay of treatment despite the availability of a wide spectrum of medications for the treatment of the disease. Surgical interventions have minimal scope in the management of the disease. Newer modalities such as stem cell therapy may perhaps hold a future for preventing disease progression
Other Latest Articles
- Case Report: Changes in Spatial Summation for Chromatic Stimuli in a Patient with Hypothyroidism Due to Autoimmune Thyroiditis Before and After Treatment with Levothyroxine
- The Conceptual Study on Medoroga
- Role of Rasayana in Female Infertility in Relation with PCOS
- Clinical Study of Arohana Matra Basti in Kevala Vataja Katigraha Vis-A- Vis Lumbar Spondylosis
- Fabrication of Oxaliplatin Microemulsion for Enhanced Cytotoxicity against Colon Cancer Cells
Last modified: 2020-06-16 18:26:12